Inside the Markets
A
AbbVie Inc.
Description
AbbVie is a research-driven biopharmaceutical company known for Humira (immunology) and a growing portfolio in oncology, neuroscience, and aesthetics (Allergan/Botox). It faces Humira biosimilar competition but has diversified its revenue base.
Key risks
humira-biosimilar-erosion
This risk may negatively affect the instrument’s performance under certain market conditions.
pipeline-dependence
This risk may negatively affect the instrument’s performance under certain market conditions.
acquisition-integration
This risk may negatively affect the instrument’s performance under certain market conditions.
The list of risks is not exhaustive and highlights the most material structural and market-related factors.
Portfolio role & behavior
Economic role
incomecore-holding
Behavior
defensivequality
The information provided is for analytical and informational purposes only and does not constitute investment advice.
Any decisions are made independently by the user and at their own risk.
For details, see legal terms.